Thermo Fisher Scientific
(NYSE) TMO
Thermo Fisher Scientific Financials at a Glance
Market Cap
$176.23B
Revenue (TTM)
$44.56B
Net Income (TTM)
$6.71B
EPS (TTM)
$17.74
P/E Ratio
26.74
Dividend
$1.76
Beta (Volatility)
0.87 (Low)
Dividend
$1.76
Beta (Volatility)
0.87 (Low)
Price
$474.49
Volume
56,857
Open
$469.07
Price
$474.49
Volume
56,857
Open
$469.07
Previous Close
$474.49
Daily Range
$469.07 - $476.89
52-Week Range
$385.46 - $643.99
Dividend
$1.76
Beta (Volatility)
0.87 (Low)
Price
$474.49
Volume
56,857
Open
$469.07
Previous Close
$474.49
Daily Range
$469.07 - $476.89
52-Week Range
$385.46 - $643.99
TMO News
TMO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Thermo Fisher Scientific
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
125,000
CEO
Marc N. Casper, MBA
Website
www.thermofisher.comHeadquarters
Waltham, MA 02451, US
TMO Financials
Key Financial Metrics (TTM)
Gross Margin
39%
Operating Margin
18%
Net Income Margin
15%
Return on Equity
13%
Return on Capital
8%
Return on Assets
6%
Earnings Yield
3.74%
Dividend Yield
0.00%
Payout Ratio
9.47%
Stock Overview
Market Cap
$176.23B
Shares Outstanding
371.48M
Volume
56.86K
Short Interest
0.00%
Avg. Volume
2.29M
Financials (TTM)
Gross Profit
$16.78B
Operating Income
$8.11B
EBITDA
$11.47B
Operating Cash Flow
$7.82B
Capital Expenditure
$1.52B
Free Cash Flow
$6.29B
Cash & ST Invst.
$10.11B
Total Debt
$40.85B
Thermo Fisher Scientific Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.21B
+7.2%
Gross Profit
$4.64B
+3.8%
Gross Margin
37.95%
N/A
Market Cap
$176.23B
N/A
Market Cap/Employee
$1.41M
N/A
Employees
125,000
N/A
Net Income
$1.98B
+7.9%
EBITDA
$3.21B
+4.8%
Quarterly Fundamentals
Net Cash
$30.75B
-13.0%
Accounts Receivable
$10.57B
+9.8%
Inventory
$5.42B
+9.0%
Long Term Debt
$37.05B
+22.3%
Short Term Debt
$3.81B
+53.9%
Return on Assets
6.09%
N/A
Return on Invested Capital
8.41%
N/A
Free Cash Flow
$2.99B
+6.5%
Operating Cash Flow
$3.46B
+5.1%